Molecular Tumor Board


Breast Cancer Tumor Board


Gastrointestinal Tract Tumor Board


Lung Cancer Tumor Board


Virtual Molecular Tumor Boards

NeoGenomics would like to invite you to our Molecular Tumor Boards. During each meeting, multidisciplinary teams will have a live discussion consulting on multiple cases with expert oncologists and discuss optimal treatment plans. Previous and upcoming topics include non-small cell lung cancer, breast cancer, and more.

Case Submission for Oncologists

Programming is subject to cancellation provided the significance of cases. To provide cases, please reach out to

If you are unable to attend our Tumor Board series, but would like a case discussed in your absence, the NeoGenomics Tumor Board moderator will discuss your case with the panelists, and our team will provide you a summary of the discussion following the tumor board. Reach out to

Previous Tumor Board Recordings

NeoGenomics Clients can view previous Tumor Boards through NeoUniversity, NeoGenomics’ on-demand learning portal – click here. To sign up for NeoUniversity, contact your Territory Business Manager or email the NeoGenomics Training Team.

Moderators Include

Dr. Narjust Duma profile image
Medical Oncologist and Assistant Professor of Medicine in the Division of Hematology, Medical Oncology, and Palliative Care @UWHealth
Dr. Hatim Husain profile image
Medical Oncologist and Associate Professor of Medicine at University of California, San Diego, Moores Cancer Center
Dr. Razelle Kurzrock profile image
Chief Medical Officer
Dr. Edgardo Santos profile image
Medical Oncologist and Founding Partner at Florida Precision Oncology
Rodolfo Bordoni MD profile image
Medical Oncologist and Director of the Clinical Research Program at Georgia Cancer Specialists
Shumei Kato MD profile image
Shumei Kato, MD
Assistant Professor, Department of Medicine @UC San Diego Health

​​​​​​​Frequently Asked Questions

A Tumor Board gathers multidisciplinary teams for discussing cases of cancer patients, to ensure optimal treatment for the patient. NeoGenomics hosts Tumor Boards—privately for client practices and hospitals, and publicly for all to attend—as an avenue for healthcare professionals to discuss optimal treatment plans, with all participants focused on improving patient care.

All PHI (Protected Health Information) is removed before the case is shared for discussion. NeoGenomics is committed to full compliance with all applicable federal and state laws and regulations, third party payer requirements, and industry best practices. For more information, see our Health Information Privacy Practices.

Reach out to to start the process.